ci 994 and tretinoin
ci 994 has been researched along with tretinoin in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Belosay, A; Gediya, LK; Khandelwal, A; Mehta, J; Njar, VC; Patel, J; Purushottamachar, P; Sabnis, G | 1 |
Belosay, A; Gediya, LK; Khandelwal, A; Njar, VC; Purushottamachar, P | 1 |
Other Studies
2 other study(ies) available for ci 994 and tretinoin
Article | Year |
---|---|
Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Carbamates; Cell Line, Tumor; Cell Proliferation; Drug Design; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Mice; Mice, SCID; Molecular Structure; Prodrugs; Prostatic Neoplasms; Structure-Activity Relationship; Tretinoin | 2008 |
Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Imidazoles; Male; Neoplasms, Experimental; Phenylenediamines; Prostatic Neoplasms; Pyridines; Transplantation, Heterologous; Tretinoin | 2008 |